We noticed you are on our AU page. Want to switch regions? Choose from the options:

Heart Disease

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk.

Trial overview

Topic

Aortic valve stenosis

Eligibility criteria

To be considered for this study you must meet the following criteria:

  • 18 years of age or older 
  • Have a Society of Thoracic Surgeons (STS) score of ≥7% OR documented heart team agreement of high or extreme risk for surgical aortic valve replacement due to frailty or co-morbidities not captured by the STS score. 
  • Have symptomatic, severe aortic stenosis as demonstrated by NYHA Functional Classification of II, III or IV

Study details

Your participation in this study would be for approximately 5 years.   

 You will need to undergo a minimally invasive surgical procedure to have the valve inserted and stay in hospital overnight.  You will then be seen in the clinic at 30 days, 12 months and then annually thereafter up to 5 years post-procedure. During these visits you will be asked about your health, medications, have a physical examination, 6-minute walk test, blood test, an ultrasound of your heart and ECG performed.

Further information

For further information regarding this clinical trial click here.

Location

Mater Brisbane (Cardiology)

Wesley Hospital Auchenflower (Cardiology Consulting)

Leabrook (Cardiology)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.